December 12, 2012
PathoGenetix, Inc., a commercial-stage developer of an automated system for rapid identification and typing of bacteria strains, today announced that John W. Czajka, Ph.D., M.B.A. has joined the company as Vice President of Business Development. Dr. Czajka will coordinate the commercial application of the company’s proprietary Genome Sequence Scanning™ (GSS™) technology for food safety testing [...]
Danaher Corporation Reaffirms 2012 Guidance and Initiates 2013 Outlook
December 12, 2012
WASHINGTON, D.C., - Ahead of an institutional investor and analyst meeting to be held in New York, Danaher Corporation (NYSE:DHR) reaffirmed the Company's diluted net earnings per share from continuing operations guidance of $0.80 - $0.85 for the fourth quarter 2012 and $3.14 to $3.19 for the full year 2012. The Company anticipates that 2013 [...]
Notice Regarding the Scheduled Transfer of Shares of SII NanoTechnology Inc. (Update)
December 12, 2012
Hitachi High-Technologies Corporation (TOKYO: 8036, Hitachi High-Tech), as reported in an earlier release titled, “Hitachi High-Tech Signs Memorandum of Understanding Regarding Acquisition and Subsequent Consolidation of SII NanoTechnology Inc.,entered a basic agreement on May 24, 2012 with Seiko Instruments Inc. (SII) to acquire all shares of SII wholly owned subsidiary SII NanoTechnology Inc. (SII NanoTech). [...]
Sequenom Announces Leadership Appointments
December 11, 2012
SAN DIEGO, -- Sequenom, Inc. (Nasdaq: SQNM) announced today the appointments of William Welch as the Company's President and Chief Operating Officer and Dirk van den Boom as the Company's Executive Vice President, Research & Development and Chief Technology Officer, both effective immediately. Additionally, Ronald Lindsay has been named as the Company's Executive Vice President, [...]
Roche 454 Sequencing Systems successfully resolve genetic mutations in over 4,000 blood cancer cases
December 11, 2012
International study presented at American Society of Hematology Meeting demonstrates the potential of 454 Sequencing Systems to comprehensively characterize an individual's blood cancer type to guide personalized therapy decisions At the American Society of Hematology Meeting (ASH) Roche announced today the presentation of results from the large scale study IRON-II through an international research consortium. [...]
December 11, 2012
ST. LOUIS, -- Sigma-Aldrich Corporation (Nasdaq: SIAL) was recently named to The Civic 50, a national ranking that recognizes the leading community-minded companies in the U.S. Based on a survey conducted by the National Conference on Citizenship (NCoC), a non-profit organization that champions civic leadership, and Points of Light, a non-partisan volunteer organization, The Civic [...]
Cole-Parmer Releases Updated Symmetry® EC Toploading Balances
December 11, 2012
With an updated design, the popular Cole-Parmer® Symmetry® EC Toploading Balances are an even more exceptional choice in weighing. For general-purpose weighing applications, these laboratory balances or weigh scales offer accuracy and traceability, including a print function for GLP compliance. The balances now include a bigger screen and easier-to-use keypad. A no-hassle single-unit draft shield [...]
December 11, 2012
WILMINGTON, Del.-- Rigrodsky & Long, P.A. has commenced a class action asserting violations of the Federal securities laws by Pacific Biosciences of California, Inc. (“PACB” or the “Company”) (NASDAQ GS: PACB) on behalf of PACB shareholders. On April 6, 2012, the Court appointed Rigrodsky & Long, P.A. lead counsel in connection with the litigation. If [...]
December 11, 2012
SAN DIEGO, CA –— Genalyte, Inc. today announced that it has been awarded a Small Business Innovation Research (SBIR) grant to develop multiplexed diagnostic assays for the early detection and monitoring of Type 1 diabetes that will run on Genalyte’s innovative MaverickTM Detection System. The $500,000 grant is from the National Institute of Diabetes and [...]
Genomic Research Service Provider DNA Link Purchases 10 Ion Proton Sequencers
December 11, 2012
CARLSBAD, Calif., -- Life Technologies Corporation (NASDAQ: LIFE) today announced that DNA Link Inc., a Korean genomic research service provider, has placed an order to purchase ten Ion Proton™ Sequencers, which are shipping immediately. To watch a short interview with DNA Link's CEO, Dr. Jong Eun Lee, click here. Life Technologies introduced the Ion Proton™ [...]

